What We’re Watching on Capitol Hill
Prescription Drug Pricing | Mar. 21, 2019

March 21, 2019 Our Government Affairs team is monitoring bills and action items that would affect the insurance industry. Here’s what we’re focusing on as of late: The “Short on

A Look at Current Single-Payer Systems
Prescription Drug Pricing | Feb. 21, 2019

The team at NFP resets the dialogue on government-run health systems by exploring how they work in the UK, Canada and here in the U.S. within the Veterans Affairs (VA) program.

Tech Giants Poised to Shift Healthcare Landscape
Prescription Drug Pricing | Dec. 5, 2018

December 5, 2018 Tech companies are banging down the doors of the healthcare industry, infiltrating different pieces of a complicated system in an effort to inject innovation into care delivery

An Update on Prescription Drug Legislation
Prescription Drug Pricing | Dec. 5, 2018

December 5, 2018 Legislative and regulatory efforts to reduce drug costs is a top priority for both Democrats and Republicans in the next Congress, and it’s one of the few

Pharmacy Supply Chain: What You Need to Know
Prescription Drug Pricing | Nov. 8, 2018

November 8, 2018 Despite the Trump administration’s push to lower drug prices, costs have not yet decreased. Lack of consensus regarding how to approach the complex pharmacy supply chain has

Medicare Part B Drug Pricing to Mirror Foreign Prices?
Prescription Drug Pricing | Nov. 8, 2018

November 8, 2018 CMS released an advanced notice of proposed rulemaking—with the spring of 2019 targeted for a proposed rule—describing changes to the way Medicare pays for some drugs administered

« Previous PageNext Page »